RichHealth metaReach UMB305-0510, Руководство пользователя

Страница: 6 / 47

6
IFU-USA-2019-Rev.001
Chapter 1 About metaReach® CGMs
1.1 Indications for Use
The metaReach®CGMs is indicated for measuring interstitial fluid glucose levels
intended users /patients (age 18 and older) with diabetes mellitus. The Patient
is an intended operator.
This product composed of three elements which are patch(with 1 mm long
microneedle), receiver and transmitter.
Users may place the patch fixed with transmitter on upper arm, and users may
continuously get glucose result via transmitter for 24 hours.
The metaReach®CGMs detection range is defined as 40 ~ 400 mg/dL.
Cautions:
Contact your healthcare professional, if the following issue cannot be resolved:
1. The result of this product is only for self-monitoring reference not for
diagnosis; do not change the therapy according to metaReach®CGMs test
result without consulting healthcare professional.
2. If the glucose result does not match your feelings, please apply a finger blood
glucose testing to confirm. If this issue remains, please remove old patch and
replace a set of new one.